Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL

Clinical trial NCT00520208 · COMPLETED

Trial details

NCT number: NCT00520208
Sponsor: CytRx
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Promyelocytic Leukemia

Start date: 2007-09-01
Primary completion: 2012-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.